Get started
Author

Adamantia Nikolaidi

Observed names: A. Nikolaidi, ADAMANTIA NIKOLAIDI, Adamantia Nikolaidou, Nikolaidi Adamantia
Institution: Mitera Hospital
ORCID: 0000-0003-2057-9585
Observed ORCID: 0000-0003-2057-9585
OpenAlex ID: A5021315519
Alveolar bone histological necrosis observed prior to extractions in patients, who received bone‐targeting agents
2020 · Ourania Nicolatou‐Galitis, Erofili Papadopoulou, et al. · Oral Diseases · 65
Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology Group
2020 · Elena Fountzilas, Georgia-Angeliki Koliou, et al. · ESMO Open · 44
Real-world safety and efficacy data of immunotherapy in patients with cancer and autoimmune disease: the experience of the Hellenic Cooperative Oncology Group
2021 · Elena Fountzilas, Sofia Lampaki, et al. · Cancer Immunology Immunotherapy · 40
PDF
Neoadjuvant treatment in ovarian cancer: New perspectives, new challenges
2022 · Adamantia Nikolaidi, Elena Fountzilas, et al. · Frontiers in Oncology · 38
PDF
Oral ulcers in patients with advanced breast cancer receiving everolimus: a case series report on clinical presentation and management
2013 · Ourania Nicolatou-Galitis, Adamantia Nikolaidi, et al. · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · 28
The Impact of Thromboprophylaxis on the Survival of Patients with Advanced Pancreatic Cancer. The Pancreatic Cancer and Tinzaparin (PaCT) Study
2021 · Michalis V. Karamouzis, Ilias Athanasiadis, et al. · Cancers · 18
PDF
Clinical Significance of Germline Cancer Predisposing Variants in Unselected Patients with Pancreatic Adenocarcinoma
2021 · Elena Fountzilas, Alexia Eliades, et al. · Cancers · 17
PDF
MINOAS: A Single-arm Translational Phase II Trial of FOLFIRI Plus Aflibercept as First-line Therapy in Unresectable, Metastatic Colorectal Cancer
2019 · Alexios Matikas, John Souglakos, et al. · Targeted Oncology · 13
Real-World Data on Health-Related Quality of Life Assessment in Patients With Breast Cancer Receiving Subcutaneous Trastuzumab
2018 · John Syrios, Evelina Pappa, et al. · Breast Cancer Basic and Clinical Research · 12
PDF
Real-world safety and effectiveness data of trastuzumab deruxtecan and sacituzumab govitecan in breast cancer: a Hellenic Cooperative Oncology Group study
2025 · E. Fountzilas, S. Karageorgopoulou, et al. · ESMO Real World Data and Digital Oncology · 9
PDF
Tumor Mutational Patterns and Infiltrating Lymphocyte Density in Young and Elderly Patients With Breast Cancer
2020 · ADAMANTIA NIKOLAIDI, VASSILIKI KOTOULA, et al. · Cancer Genomics & Proteomics · 9
PDF
Real-world efficacy and toxicity data of paclitaxel and ramucirumab compared with other treatment regimens in patients with advanced gastric cancer
2024 · E. Fountzilas, J. Souglakos, et al. · ESMO Gastrointestinal Oncology · 4
PDF
Real-World Data on Treatment Management and Outcomes of Patients with Newly Diagnosed Advanced Epithelial Ovarian Cancer in Greece (The EpOCa Study)
2021 · Michalis Liontos, Eleni Timotheadou, et al. · Current Oncology · 3
PDF
Clinical outcome and toxicity data in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy in a real-world clinical setting
2019 · E. Fountzilas, G.-A. Koliou, et al. · Annals of Oncology · 3
PDF
Real-world management strategies and clinical outcomes of metastatic HER2-positive breast cancer in Greece in the second-line setting and beyond (the togetHER study)
2025 · Ippokratis Korantzis, Anna Koumarianou, et al. · BMC Cancer · 2
PDF
Real-World Toxicity and Effectiveness Study of Abemaciclib in Greek Patients with Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Multi-Institutional Study
2025 · Elena Fountzilas, Eleni Aravantinou-Fatorou, et al. · Cancers · 2
PDF
Molecular Alterations in Paired Epithelial Ovarian Tumors in Patients Treated with Neoadjuvant Chemotherapy
2024 · Adamantia Nikolaidi, Eirini Papadopoulou, et al. · Cancers · 2
Real-world Data and Economic Evaluation of Nivolumab in Previously Treated Non-small Cell Lung Cancer Greek Patients
2023 · HELENA LINARDOU, SOFIA LAMPAKI, et al. · Anticancer Research · 2
PDF
Validation of Patras Immunotherapy Score model for prediction and prognosis of patients with advanced NSCLC treated with nivolumab or pembrolizumab: results from a European multicentre study
2022 · Foteinos-Ioannis Dimitrakopoulos, Giannis Mountzios, et al. · Therapeutic Advances in Medical Oncology · 2
A Patient Affected with Serous Ovarian/Peritoneal Carcinoma Carrying the FANCM Mutation
2019 · Adamantia Nikolaidi, Irene Konstantopoulou, et al. · Case Reports in Oncological Medicine · 2
PDF
Langerhans cell histiocytosis following treatment for testicular cancer. A case report and literature review
2015 · Pistamaltzian Nikolaos, Nikolaidi Adamantia, et al. · Forum of Clinical Oncology · 2
PDF
Real-world data on the safety and efficacy of trastuzumab deruxtecan and sacituzumab govitecan in patients with advanced breast cancer: the experience of the Hellenic Cooperative Oncology Group
2024 · E. Fountzilas, T. Lalla, et al. · European Journal of Cancer · 1
PDF
Pbi34 Budget Impact of Trastuzumab Biosimilars for the Treatment of Breast Cancer and Gastric Cancer in Greece
2019 · A. Solakidi, I. Kougioumtzoglou, et al. · Value in Health · 1
Abstract P4-07-30: The prognostic and predictive value of Oncotype DX® in ER+/HER2-/pT2N0, cM0 Breast Cancer Patients
2025 · Ioannis Natsiopoulos, Venizelos Vasileios, et al. · Clinical Cancer Research
Abstract P4-09-29: PR status cannot predict Oncotype DX Recurrence Score®: a study in a Greek cohort of N0M0/ER+/PR-/HER2- breast cancer patients tested with Oncotype DX
2025 · Vasileios Venizelos, Rodoniki Iosifidou, et al. · Clinical Cancer Research
Works count: 33
Citation count: 319
H-index: 9
I10-index: 9
Year
Topic
Type